Insights

Filters   Sort By Newest  
Newest Oldest Title
Updating results

Showing results 1 - 19 of 19 Results per page:

No results found.

  • Advertising, Marketing & Regulatory
  • Artificial Intelligence
  • Automotive
  • Cannabis
  • Chemical
  • Chemical AI
  • Cleantech
  • Copyright & Digital Media
  • Electrical & Computer Technology
  • Financial Technology
  • Industrial Designs
  • IP Management & Strategic Counselling
  • Licensing & Transactions
  • Life Sciences
  • Litigation & Contentious IP
  • Mechanical & Industrial Processes
  • Medical Technology
  • Nanotechnology
  • Oil & Gas
  • Patents
  • Plant Breeders’ Rights
  • Privacy & Data Protection
  • Psychedelics
  • Quantum Technologies
  • Trademarks
  • Nicholas Aitken
  • Arvin Angue
  • Adam Aucoin
  • William Audet
  • Ryan Baker
  • Christie J. C. Bates
  • Stephen Beney
  • Brett Benham
  • Daniel Bereskin, C.M., K.C.
  • Janice M. Bereskin
  • Shaivi Bhatt
  • Adam Bierylo
  • Paul David Blizzard
  • Adam Bobker
  • Chantalle Briggs
  • Jonathan G. Burkinshaw
  • Isi Caulder
  • Brigitte Chan
  • Wynnie Chan
  • Mina Chana
  • Herman Cheung
  • Kyle Classen
  • Toba Cooper
  • Noel Courage
  • Carmela De Luca
  • Ryan De Vries
  • Reshika Dhir
  • Meghan Dillon
  • Michael Fenwick
  • Patricia Folkins
  • Cameron Gale
  • Matthew John Graff
  • Louis-Pierre Gravelle
  • Micheline Gravelle
  • Gail Hung
  • Nicole Hunter
  • Jason Hynes
  • Alissa Hyppolite
  • Ellen Kiernan
  • Simone Knott
  • Ray Kovarik
  • Chris Kowal
  • Victor Krichker
  • Dominique Lambert
  • François Larose
  • Julia London
  • Maddie Lynch
  • Joanna Ma
  • Alfred A. Macchione
  • R. Scott MacKendrick
  • Don MacOdrum
  • Sandra Marone
  • Andrew McIntosh
  • Melissa J. McKeon
  • Ian McMillan
  • Philip C. Mendes da Costa
  • David Morrison
  • Luba Naiberger
  • Paige Newman
  • Andrea Ngo
  • Tony Orsi
  • Ainslie Parsons
  • Moïse Perreault
  • Justin Philpott
  • Scott Pundsack
  • James Raakman
  • Bhupinder Randhawa
  • Sunil Rao
  • Mark L. Robbins
  • Jane Sarjeant
  • Timothy Sinnott
  • Parnian Soltanipanah
  • Josh Spicer
  • David St-Martin
  • Kate Stewart-Tiralongo
  • Robert Storey
  • Jessica R. Sudbury
  • Melanie Szweras
  • Andrea Uetrecht
  • Charles Wang
  • Maria Wei
  • Tamara Céline Winegust
  • Leanne Young
  • Jennie Yum
  • Previous 30 days
  • Previous 90 days
  • Previous year
  • From to

Explore our Insights

September 6, 2023
Antibody Patents in the U.S. & Japan: If You Claim More, You Better Enable More
By Jessica R. Sudbury & Carmela De Luca
›
July 25, 2022
Patentable Subject Matter, Indefiniteness and the Obvious to Try Test – “Multi-Pack” Lessons from the Patent Appeal Board decision Re: Illinois Tool Works Inc.
By Carmela De Luca and Benjamin Todd
›
June 21, 2022
Excess patent claim fees and Canadian double patenting – unintended consequences?
›
October 6, 2021
AI in Focus: the Human Microbiome
By Iris Cheung and Carmela De Luca
›
March 11, 2021
Patenting Biologics and Other Therapeutics in the United States: Another Strike Against Claims with Functional Limitations
By Alissa Hyppolite, Shuo Xing and Carmela De Luca
›
February 11, 2021
Patent Application Extensions of Time in Canada
By Carmela De Luca and Alissa Hyppolite
›
December 4, 2020
Is Canada on the Brink of AI and Diagnostics Patent Rush?
›
September 15, 2020
Recording Assignments, Transfers and Changes of Name in Canada Are Now Less Onerous
By Carmela De Luca and Alissa Hyppolite
›
April 29, 2020
Pooling Patent Rights to Combat COVID-19
By Noel Courage, Carmela De Luca and Aaraf Dewan
›
April 22, 2020
Patents and Their Role in a COVID-19 Cure
By Melanie Szweras and Carmela De Luca
›
March 18, 2020
New 2021 Tax Deduction for Intellectual Property Protected Innovations in Québec
By Carmela De Luca and Alissa Hyppolite
›
January 31, 2020
Québec and Federal Governments can Support Your Innovative Projects
By Carmela De Luca and Alissa Hyppolite
›

Subscribe to our newsletter

You can unsubscribe at any time. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

September 17, 2019
Another Round in the US CRISPR Patent Dispute
By Ainslie Parsons and Carmela De Luca
›
November 29, 2018
Amgen v Sanofi – Neutralizing Antibody to Antigen Claims
By Donald Bocchinfuso and Carmela De Luca 
›
September 26, 2018
Broad Institute Prevails in Recent Round of the US CRISPR Patent Battle
By Ainslie Parsons and Carmela De Luca
›
August 2, 2018
The Battle to Control CRISPR IP Continues
By Carmela De Luca and Ainslie Parsons
›
December 15, 2017
Carmela De Luca coauthors article in Molecular Diagnosis & Therapy published by Springer Nature, “Gene Patents in Canada: Is There a New Legal Landscape?” 
›
November 13, 2017
Canadian diagnostic claims – where do we stand?
By Carmela De Luca
›
October 17, 2017
Feature Story in Pharmaceutical Engineering Magazine Penned by Ainslie Parsons and Carmela De Luca
›
Loading...

Showing results 1 - 19 of 19 Results per page:

No results found.

Subscribe to our newsletter

You can unsubscribe at any time. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

This site is registered on wpml.org as a development site.